Creatine kinase pathway inhibition alters GSK3 and WNT signaling in EVI1-positive AML.

Leukemia
Authors
Keywords
Year of Publication
2019
Journal
Leukemia
Volume
33
Issue
3
Pages
800-804
Date Published
2019 Mar
ISSN
1476-5551
DOI
10.1038/s41375-018-0291-x
PubMed ID
30390009
PubMed Central ID
PMC6596421
Links
Grant list
R35 CA210030 / CA / NCI NIH HHS / United States